US6979471090
US6979471090
Palvella Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 38.602.000 | 14.095.000 | 173.9% | |
| Operating Income | -38.602.000 | -14.095.000 | 173.9% |
| Pretax Income | -41.715.000 | -17.434.000 | 139.3% |
| Net Income Common Stockholders | -41.715.000 | -17.434.000 | 139.3% |
| -- | -- | -- | |
| -- | -- | -- |